As of 2026-05-20, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -4.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 161.23 mil USD. AVITA's TTM EBITDA according to its financial statements is -39.82 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 15.5x | 14.9x |
| Forward P/E multiples | 17.8x - 24.6x | 19.8x |
| Fair Price | (24.23) - (21.24) | (23.62) |
| Upside | -677.7% - -606.4% | -663.1% |
| Date | EV/EBITDA |
| 2026-05-15 | -4.33 |
| 2026-05-14 | -4.18 |
| 2026-05-13 | -4.10 |
| 2026-05-12 | -4.19 |
| 2026-05-11 | -4.18 |
| 2026-05-08 | -3.98 |
| 2026-05-07 | -4.04 |
| 2026-05-06 | -4.22 |
| 2026-05-05 | -4.08 |
| 2026-05-04 | -4.11 |
| 2026-05-01 | -4.24 |
| 2026-04-30 | -4.15 |
| 2026-04-29 | -4.08 |
| 2026-04-28 | -4.15 |
| 2026-04-27 | -4.33 |
| 2026-04-24 | -4.25 |
| 2026-04-23 | -4.15 |
| 2026-04-22 | -4.41 |
| 2026-04-21 | -4.49 |
| 2026-04-20 | -4.67 |
| 2026-04-17 | -4.78 |
| 2026-04-16 | -4.66 |
| 2026-04-15 | -4.79 |
| 2026-04-14 | -5.13 |
| 2026-04-13 | -4.60 |
| 2026-04-10 | -4.68 |
| 2026-04-09 | -4.31 |
| 2026-04-08 | -3.98 |
| 2026-04-07 | -3.80 |
| 2026-04-06 | -3.82 |
| 2026-04-02 | -3.68 |
| 2026-04-01 | -3.72 |
| 2026-03-31 | -3.67 |
| 2026-03-30 | -3.61 |
| 2026-03-27 | -3.76 |
| 2026-03-26 | -3.79 |
| 2026-03-25 | -3.89 |
| 2026-03-24 | -3.78 |
| 2026-03-23 | -3.86 |
| 2026-03-20 | -3.86 |
| 2026-03-19 | -3.92 |
| 2026-03-18 | -4.05 |
| 2026-03-17 | -4.26 |
| 2026-03-16 | -4.38 |
| 2026-03-13 | -4.21 |
| 2026-03-12 | -4.35 |
| 2026-03-11 | -4.51 |
| 2026-03-10 | -4.59 |
| 2026-03-09 | -4.64 |
| 2026-03-06 | -4.48 |